UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Reliant Investment Management LLC

Reliant Investment Management LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 424 shares of the healthcare conglomerate’s stock after selling 26 shares during the quarter. Reliant Investment Management LLC’s holdings in UnitedHealth Group were worth $214,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. M&T Bank Corp increased its stake in UnitedHealth Group by 13.4% in the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after purchasing an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC grew its position in UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after acquiring an additional 1,193 shares during the period. Benjamin Edwards Inc. grew its position in UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after acquiring an additional 41,308 shares during the period. Parsifal Capital Management LP purchased a new stake in UnitedHealth Group during the third quarter valued at about $21,165,000. Finally, Signal Advisors Wealth LLC grew its position in UnitedHealth Group by 13.0% during the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after acquiring an additional 1,051 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on UNH shares. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research report on Friday, January 10th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research report on Friday. Royal Bank of Canada decreased their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Barclays cut their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday. Finally, TD Cowen boosted their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Stock Down 0.1 %

Shares of UnitedHealth Group stock opened at $510.03 on Tuesday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The business’s 50 day simple moving average is $549.37 and its 200-day simple moving average is $563.70. The stock has a market capitalization of $469.37 billion, a price-to-earnings ratio of 32.91, a PEG ratio of 1.39 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the firm earned $5.83 EPS. The business’s quarterly revenue was up 6.8% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.77 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.